JANE STREET GROUP, LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182908. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q2 2024$11,920,007
-43.4%
220,700
-28.6%
0.00%
-25.0%
Q1 2024$21,061,440
-51.8%
309,000
-55.7%
0.00%
-63.6%
Q4 2023$43,663,500
+450.0%
697,500
+298.8%
0.01%
+266.7%
Q3 2023$7,938,711
-63.6%
174,900
-55.0%
0.00%
-57.1%
Q2 2023$21,816,004
+108.4%
388,600
+67.9%
0.01%
+75.0%
Q1 2023$10,466,222
+0.4%
231,400
-9.8%
0.00%
-20.0%
Q4 2022$10,426,725
-62.9%
256,500
-40.4%
0.01%
-58.3%
Q3 2022$28,120,000
+9.5%
430,300
+1.8%
0.01%
+9.1%
Q2 2022$25,675,000422,5000.01%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING LLC 215,800$14,103,0000.03%
IMC-Chicago, LLC 180,700$11,809,0000.02%
JANE STREET GROUP, LLC 430,300$28,120,0000.01%
SIMPLEX TRADING, LLC 110,300$7,208,0000.01%
Twin Tree Management, LP 8,100$529,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CRISPR THERAPEUTICS AG shareholders